GAITHERSBURG, Md. (WJZ) — The Gaithersburg-based company Novavax announced it expects to file for approval of its COVID-19 vaccine candidate in December.
According to Reuters, the company plans to produce part of the vaccine at its Czech plant and give the country access to the product once its approved.
- TIMELINE: Coronavirus In Maryland, Tracking The Spread
- Latest coronavirus stories from WJZ
- Latest CDC Guidelines
Earlier this week, Novavax announced it had started enrolling volunteers.